Matti Sällberg

Years Active: 2020-2022
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Sofia K Appelberg, Gustaf Ahlén, Jingyi Yan, Negin Nikouyan, Sofie Weber, Olivia Larsson, Urban Höglund, Soo Aleman, Friedemann Weber, Emma Perlhamre, Johanna Apro, Eva-Karin Gidlund, Ola Tuvesson, Simona Salati, Matteo Cadossi, Hanna Tegel, Sophia Hober, Lars Frelin, Ali Mirazimi, Matti Sällberg
A universal SARS-CoV DNA vaccine inducing highly cross-reactive neutralizing antibodies and T cells. EMBO molecular medicine 14 (10) (2022)
Rani Burm, Panagiota Maravelia, Gustaf Ahlen, Sandra Ciesek, Noelia Caro Perez, Anna Pasetto, Stephan Urban, Freya Van Houtte, Lieven Verhoye, Heiner Wedemeyer, Magnus Johansson, Lars Frelin, Matti Sällberg, Philip Meuleman
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections. Gut (2022)
Anna Pasetto, Gustaf Ahlén, Matti Sällberg
Editorial: HBV-the naked truth? Alimentary pharmacology & therapeutics 50 (8) (2020)
Anton Lutckii, Benedikt Strunz, Anton Zhirkov, Olga Filipovich, Elena Rukoiatkina, Denis Gusev, Yuriy Lobzin, Björn Fischler, Soo Aleman, Matti Sällberg, Niklas K Björkström
Evidence for B cell maturation but not trained immunity in uninfected infants exposed to hepatitis C virus. Gut 69 (12) (2020)

Matti Sällberg.css-eqlu8i{font-size:small;padding-left:4px;}